Cervical cancer tracking virtual learning object

Collaborations

Davilla MSD, Primo CC, Almeida MVS, Leite FMC, Sant’Anna HC, Jensen R and Lima EFA declare that they contributed to project design, data analysis and interpretation, article writing, relevant critical review of intellectual content and final approval of the version to be published.

Modules	Screens	Content	CVI
Module I What is Cancer	Screen 1	Educational technology to update cervical cancer tracking	100.0
	Screen 2	VLO program content	100.0
	Screen 3	Presentation screen	100.0
	Screen 4	Credits screen	100.0
	Screens 5 and 6	Content Screens: Definition on cancer	100.0
	Screen 7	Tissue Growth	100.0
	Screen 8	Oncogenesis	100.0
	Screen 9	Tumor Immunology	100.0
	Screens 10 and 11	Classification/Bbological behavior	100.0
	Screens 12 and 13	Nomenclature	100.0
Module II Cervical Cancer Epidemiology in Brazil and Worldwide	Screens 14 and 15	Cancer epidemiology	100.0
	Screens 16 and 17	Cervical cancer epidemiology in Brazil and worldwide	100.0
Module III Risk Factors for Cervical Cancer	Screens 18 and 19	Risk factors	95.2
Module IV Cervical Cancer Prevention and Female Genital Self-Examination	Screens 20 and 21	Cervical cancer prevention	100.0
	Screens 22 and 23	Female genitalia self-examination	95.2
Module V Cervical Cancer Control and Pap Smear	Screens 24 and 25	Cervical cancer control	100.0
	Screen 26	Pap smear: History	100.0
	Screens 27	Objective	100.0
	Screens 28, 29 and 30	Materials used/speculum types	100.0
	Screens 31 and 32	Fixing the material to the blade with spray and alcohol /Recommendations	95.2
	Screen 33	Spatulas/Brushes	100.0
	Screen 34	Filling in the SISCAN form/Slide identification	95.2
	Screens 35 and 36	Exam technique	95.2
	Screens 37, 38 and 39	Ectocervical collection/endocervical collection/Schiller test	100.0
	Screens 40 and 41	Fixing the material/Recommendations	95.2
	Screens 42 and 43	Exam reading and interpretation	90.5
	Screens 44 and 45	Main findings in Pap smear: Unsatisfactory sample for assessment/Satisfactory sample for assessment/Recommendations	95.2
	Screens 46 and 47	Special situations: Pregnant women/Recommendations/Postmenopausal/Recommendations/Hysterectomized/Recommendation	95.2
	Screens 48 and 49	Normal Result/Within normal limits in the material examined/Recommendations/Benign cellular changes (reactive or repair) Inflammation without agent identification/Recommendations	100.0
	Screens 50, 51 and 52	Result indicating immature squamous metaplasia/Recommendations/Result indicating repair/Recommendations/Result indicating atrophy with inflammation/recommendations/Result indicating radiation/Recommendations/Microbiological findings/Recommendations	95.2
	Screens 53, 54, 55 and 56	Special situations/Atypias of undetermined meaning in squamous cells/Atypical squamous cells of undetermined meaning, possibly non-neoplastic/Recommendations	90.5
	Screens 57 and 58	Vaginal discharge/Vaginal discharge etiology	100.0
	Screens 59 and 60	Examination of internal and external female genitalia	100.0
	Screens 61 and 62	Genitoperianal observation	100.0
	Screens 63 and 64	Vaginal touch or combined touch	100.0
	Screens 65	Nursing record in gynecological consultation	95.2

[1] Corresponding author Cândida Caniçali Primo, E-mail: candida.primo@ufes.br

Brasil

Brasil

Cervical cancer tracking virtual learning object

Abstract

Objective:

Methods:

Results:

Conclusion: